DV
Dividend Vision

ARDX — Ardelyx, Inc.

Ardelyx, Inc. (ARDX)

Total return is -71.2% over the past 12.2 years, 456.8 points behind SPY at 385.6%. Its deepest 1-year drawdown was 51.1%.

This is an individual equity security rather than an ETF—it represents shares in Ardelyx, Inc., a biopharmaceutical company. As a single stock, it does not distribute dividends and therefore carries no yield or defined expense ratio typical of fund structures. This security appeals primarily to growth-oriented investors seeking exposure to the pharmaceutical sector rather than to income-focused dividend investors.

ARDX key facts

Asset type
Stock
Asset class
Equity
Inception date
06/19/2014
Distribution frequency
None
Last close
$4.06
Market cap
$1,048,241,536
Average volume
3974600.0
Beta
0.731
Payout ratio
0.0
Forward P/E
40.6504
EPS
$-0.24